NAUT Q4 2022 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$921,000

Operating Income

-$16M

Net Income

-$13M

EPS (Diluted)

$-0.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$350M

Total Liabilities

$35M

Stockholders' Equity

$315M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$921,000	-$263,000	-250.2%
Operating Income	-$16M	-$17M	+3.0%
Net Income	-$13M	-$17M	+19.7%